The effect of diethyl carbamate as a chelating agent on the excretion of cadmium was evaluated in cadmium-poisoned Wistar rats following food and drink administration. The present research aimed to characterize the potential efficiency of diethyl carbamate as an oral drug chelator after cadmium administration for 60 days. This chelator significantly enhanced the urinary and biliary excretion of cadmium and restored the altered levels of iron. Diethyl carbamate was given orally to different groups of rats for a period of 1 week immediately after cadmium administration. After chelation therapy, animals were killed by exsanguination from abdominal aorta. Blood, kidneys, spleen, and heart samples were collected and prepared for determination of cadmium. Cadmium and iron concentrations in different issues were determined by graphite furnace and flame atomic absorption spectrometry (GFAAS and FAAS) methods, respectively. The chelation therapy results showed that diethyl carbamate was able to remove cadmium ions from different tissues while iron concentration returned to normal level and clinical symptoms were also reduced. In summary, we can conclude that diethyl carbamate could mobilize and promote the excretion of cadmium in rat organs and reduce the side-effects and general symptoms of toxicity. Moreover, it might be useful for preliminary testing of the efficiency of chelating agents in the human body. However, these results should be confirmed in a different experimental model before extrapolation to other systems. This testing procedure of course does not provide all the relevant answers for evaluating the efficiency of chelating agents in cadmium toxicity.